Wells Fargo & Company »

Ishares Tr genomics immun shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $391k 17k 23.61
2025-06-30 $306k 15k 20.51
2025-03-31 $288k 14k 20.49
2024-12-31 $293k 13k 22.63
2024-09-30 $47k 1.9k 24.61
2024-06-30 $35k 1.5k 23.12
2024-03-31 $47k 2.0k 24.09
2023-12-31 $89k 3.9k 23.01
2023-09-30 $101k 4.9k 20.35
2023-06-30 $251k 11k 23.35
2022-12-31 $177k 7.0k 25.17
2022-09-30 $168k 6.3k 26.53
2022-06-30 $196k 6.8k 28.88
2022-03-31 $300k 8.7k 34.50
2021-12-31 $1.0M 23k 45.11